1. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas;Albert;NeuroOncol,2016
2. Clinical applications of polyamine-based therapeutics;Bachmann,2012
3. Multicenter phase I study of erdafitinib (JNJ-42756493), oral pan-fibroblast growth factor receptor inhibitor, in patients with advanced or refractory solid tumors;Bahleda;Clin. Cancer Res.,2019
4. The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma;Bleeker;Acta Neuropathol. (Berl),2010
5. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013